Work

A Dual‐Responsive Senolytic Hydrogel Remodels the Postsurgical Senescent Microenvironment to Suppress Glioblastoma Recurrence

Year: 2026
Type: article
Abstract: Tumor recurrence remains the predominant cause of mortality in patients with glioblastoma (GBM), and (chemo/radio-) therapy-induced senescence (TIS) has recently been recognized as a key driver by deteriorating the post-surgical microenvironment. To exploit this "senescence trap", we developed an injectable, bacterial cellulose (BC)-based hydrogel system (ABT@Gal-gel) designed for preferential elimination of senescent GBM cells. This platform encapsulates galactose-modified polydopamine nanoparticles loaded with the senolytic agent ABT-263 (ABT@Gal-PDA). It enables programmed, β-galactosidase (β-Gal)-responsive drug release to preferentially eliminate pro-tumorigenic senescent cells. Moreover, the cellulose and chitosan in the hydrogel further remodel the immunosuppressive tumor microenvironment by inducing M1 macrophage polarization. In orthotopic GBM mouse models, this dual-functional strategy significantly inhibits tumor recurrence and prolongs overall survival. Overall, this study presents a novel strategy by coupling senescence-associated intracellular targeting with tumor-associated macrophage (TAM) repolarization to suppress GBM relapses, providing a promising direction for the next generation of postoperative brain cancer therapies.
Language: English
Subfield: Biomaterials
Open Access status: gold
Estimated APC paid: $6,730
OpenAlex ID: W7236412761
FWCI:
Cites: 41
Cited by:
Related to: 10